integrated monitoring and local wrap-around hypertension program for Hypertension

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of California, Los Angeles, Los Angeles, CA
Hypertension
integrated monitoring and local wrap-around hypertension program - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study sets out to evaluate a UC-wide (Davis, San Francisco, and Los Angeles) quality improvement initiative to increase remote (home) blood pressure monitoring and improve blood pressure control for persons with hypertension. Participants at each site will be randomized to one of two types of remote monitoring: integrated versus manual. Participants using the integrated monitoring will have their home blood pressure readings sent directly to their participating health systems. Participants using the manual monitoring will record their own blood pressures and report them to their health care system as per usual care.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Baseline, six months

Baseline, six months
Adverse events
Binary 5mm change in blood pressure
Binary measure of controlled vs uncontrolled hypertension
Continuous change in blood pressure
Exploratory pre-post analysis of overall change in BP
HTN outcomes from integrated monitor readings

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Manual
1 of 2
Integrated
1 of 2
Active Control
Experimental Treatment

660 Total Participants · 2 Treatment Groups

Primary Treatment: integrated monitoring and local wrap-around hypertension program · No Placebo Group · N/A

Integrated
Behavioral
Experimental Group · 1 Intervention: integrated monitoring and local wrap-around hypertension program · Intervention Types: Behavioral
Manual
Behavioral
ActiveComparator Group · 1 Intervention: manual monitoring and general education on use · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, six months
Closest Location: University of California, Los Angeles · Los Angeles, CA
Photo of Los Angeles 1Photo of Los Angeles 2Photo of Los Angeles 3
2004First Recorded Clinical Trial
4 TrialsResearching Hypertension
216 CompletedClinical Trials

Who is running the clinical trial?

University of California, DavisOTHER
829 Previous Clinical Trials
4,997,244 Total Patients Enrolled
7 Trials studying Hypertension
628 Patients Enrolled for Hypertension
University of California, San FranciscoOTHER
2,245 Previous Clinical Trials
11,472,966 Total Patients Enrolled
37 Trials studying Hypertension
172,573 Patients Enrolled for Hypertension
University of California, Los AngelesLead Sponsor
1,381 Previous Clinical Trials
6,520,487 Total Patients Enrolled
18 Trials studying Hypertension
1,976 Patients Enrolled for Hypertension
University of California Office of the President- Quality and Population Health ManagementUNKNOWN
Catherine Sarkisian, MD, MSHSPrincipal InvestigatorDirector, Value-Based Care Research Consortium

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have hypertension.
You have 2 or more office visits with a blood pressure recorded in the last year and still affiliated with institution.
You have a blood pressure reading of > 150/90 mmHg in the last 6 months.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.